Telaglenastat
| CAS No. | 1439399-58-2 |
|---|---|
| MDL No. | MFCD28167826 |
| MF | C26H24F3N7O3S |
| MW | 571.60 |
| InChI Key | PRAAPINBUWJLGA-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Telaglenastat is an orally bioavailable glutaminase inhibitor with potential antineoplastic activity. CB-839 selectively and irreversibly inhibits glutaminase, a mitochondrial enzyme critical for converting glutamine into glutamate. By blocking glutamine utilization, it impairs proliferation in rapidly growing cells. Glutamine-dependent tumors rely on converting exogenous glutamine into glutamate and metabolites for energy and macromolecular building blocks. It functions as an EC 3.5.1.2 (glutaminase) inhibitor.
| CAS No. | 1439399-58-2 |
|---|---|
| Product Name | Telaglenastat |
Biological Targets
GLS
Associated Conditions
cervical carcinoma·clear cell renal carcinoma·non-small cell lung carcinoma·renal cell carcinoma·prostate cancer·
* The information provided here is compiled from public sources and is for reference only.
